Followers | 16 |
Posts | 1145 |
Boards Moderated | 0 |
Alias Born | 03/12/2010 |
Tuesday, November 05, 2019 12:47:08 PM
Recent IDYA News
- IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event • PR Newswire (US) • 05/01/2024 10:00:00 AM
- IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 04/26/2024 10:00:00 AM
- IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study • PR Newswire (US) • 04/24/2024 02:05:00 PM
- IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer • PR Newswire (US) • 04/22/2024 10:00:00 AM
- IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 04/05/2024 10:00:00 AM
- IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Event • PR Newswire (US) • 04/01/2024 10:00:00 AM
- IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer • PR Newswire (US) • 03/12/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:27:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:26:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:24:52 PM
- IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events • PR Newswire (US) • 03/04/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/20/2024 09:31:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:07:03 AM
- IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update • PR Newswire (US) • 02/20/2024 11:00:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:44:22 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 12:31:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:59:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/09/2024 10:56:04 PM
- IDEAYA Biosciences to Participate in Upcoming February 2024 Investor Relations Events • PR Newswire (US) • 02/01/2024 11:00:00 AM
- IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 01/26/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 12:12:09 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 11:03:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 10:18:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/19/2024 10:15:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:41:04 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM